177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Clinical trial NCT07677566 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07677566
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Patients

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.